Active specific immunotherapy in ovarian cancer.
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001500:BCG Vaccine / Q000627:therapeutic use*; D002478:Cells, Cultured / Q000528:radiation effects; D002945:Cisplatin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007167:Immunotherapy; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000628:therapy*; D014184:Transplantation, Homologous
D000970:Antineoplastic Agents; D001500:BCG Vaccine; D004317:Doxorubicin; D003520:Cyclophosphamide; D002945:Cisplatin